Table of Content

1 Long-acting EPO Drugs Market Overview
1.1 Product Overview and Scope of Long-acting EPO Drugs
1.2 Long-acting EPO Drugs Segment by Type
1.2.1 Global Long-acting EPO Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin-alfa
1.2.5 Others
1.3 Long-acting EPO Drugs Segment by Application
1.3.1 Global Long-acting EPO Drugs Market Value by Application: (2024-2034)
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Global Long-acting EPO Drugs Market Size Estimates and Forecasts
1.4.1 Global Long-acting EPO Drugs Revenue 2018-2029
1.4.2 Global Long-acting EPO Drugs Sales 2018-2029
1.4.3 Global Long-acting EPO Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Long-acting EPO Drugs Market Competition by Manufacturers
2.1 Global Long-acting EPO Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Long-acting EPO Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Long-acting EPO Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Long-acting EPO Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Long-acting EPO Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting EPO Drugs, Product Type & Application
2.7 Long-acting EPO Drugs Market Competitive Situation and Trends
2.7.1 Long-acting EPO Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Long-acting EPO Drugs Players Market Share by Revenue
2.7.3 Global Long-acting EPO Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Long-acting EPO Drugs Retrospective Market Scenario by Region
3.1 Global Long-acting EPO Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Long-acting EPO Drugs Global Long-acting EPO Drugs Sales by Region: 2018-2029
3.2.1 Global Long-acting EPO Drugs Sales by Region: 2018-2024
3.2.2 Global Long-acting EPO Drugs Sales by Region: 2024-2029
3.3 Global Long-acting EPO Drugs Global Long-acting EPO Drugs Revenue by Region: 2018-2029
3.3.1 Global Long-acting EPO Drugs Revenue by Region: 2018-2024
3.3.2 Global Long-acting EPO Drugs Revenue by Region: 2024-2029
3.4 North America Long-acting EPO Drugs Market Facts & Figures by Country
3.4.1 North America Long-acting EPO Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Long-acting EPO Drugs Sales by Country (2018-2029)
3.4.3 North America Long-acting EPO Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting EPO Drugs Market Facts & Figures by Country
3.5.1 Europe Long-acting EPO Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Long-acting EPO Drugs Sales by Country (2018-2029)
3.5.3 Europe Long-acting EPO Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting EPO Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Long-acting EPO Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Long-acting EPO Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Long-acting EPO Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting EPO Drugs Market Facts & Figures by Country
3.7.1 Latin America Long-acting EPO Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Long-acting EPO Drugs Sales by Country (2018-2029)
3.7.3 Latin America Long-acting EPO Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Long-acting EPO Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting EPO Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Long-acting EPO Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Long-acting EPO Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting EPO Drugs Sales by Type (2018-2029)
4.1.1 Global Long-acting EPO Drugs Sales by Type (2018-2024)
4.1.2 Global Long-acting EPO Drugs Sales by Type (2024-2029)
4.1.3 Global Long-acting EPO Drugs Sales Market Share by Type (2018-2029)
4.2 Global Long-acting EPO Drugs Revenue by Type (2018-2029)
4.2.1 Global Long-acting EPO Drugs Revenue by Type (2018-2024)
4.2.2 Global Long-acting EPO Drugs Revenue by Type (2024-2029)
4.2.3 Global Long-acting EPO Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Long-acting EPO Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Long-acting EPO Drugs Sales by Application (2018-2029)
5.1.1 Global Long-acting EPO Drugs Sales by Application (2018-2024)
5.1.2 Global Long-acting EPO Drugs Sales by Application (2024-2029)
5.1.3 Global Long-acting EPO Drugs Sales Market Share by Application (2018-2029)
5.2 Global Long-acting EPO Drugs Revenue by Application (2018-2029)
5.2.1 Global Long-acting EPO Drugs Revenue by Application (2018-2024)
5.2.2 Global Long-acting EPO Drugs Revenue by Application (2024-2029)
5.2.3 Global Long-acting EPO Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Long-acting EPO Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Long-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Amgen Long-acting EPO Drugs Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Long-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Johnson & Johnson Long-acting EPO Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Kyowa Kirin
6.3.1 Kyowa Kirin Corporation Information
6.3.2 Kyowa Kirin Description and Business Overview
6.3.3 Kyowa Kirin Long-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Kyowa Kirin Long-acting EPO Drugs Product Portfolio
6.3.5 Kyowa Kirin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting EPO Drugs Industry Chain Analysis
7.2 Long-acting EPO Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting EPO Drugs Production Mode & Process
7.4 Long-acting EPO Drugs Sales and Marketing
7.4.1 Long-acting EPO Drugs Sales Channels
7.4.2 Long-acting EPO Drugs Distributors
7.5 Long-acting EPO Drugs Customers
8 Long-acting EPO Drugs Market Dynamics
8.1 Long-acting EPO Drugs Industry Trends
8.2 Long-acting EPO Drugs Market Drivers
8.3 Long-acting EPO Drugs Market Challenges
8.4 Long-acting EPO Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Long-acting EPO Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Long-acting EPO Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Long-acting EPO Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Long-acting EPO Drugs Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Long-acting EPO Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Long-acting EPO Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Long-acting EPO Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Long-acting EPO Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Long-acting EPO Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Long-acting EPO Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Long-acting EPO Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Long-acting EPO Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-acting EPO Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting EPO Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-acting EPO Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Long-acting EPO Drugs Sales by Region (2018-2024) & (K Units)
Table 18. Global Long-acting EPO Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Long-acting EPO Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Long-acting EPO Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Long-acting EPO Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Long-acting EPO Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Long-acting EPO Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Long-acting EPO Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Long-acting EPO Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Long-acting EPO Drugs Sales by Country (2018-2024) & (K Units)
Table 27. North America Long-acting EPO Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Long-acting EPO Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Long-acting EPO Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Long-acting EPO Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Long-acting EPO Drugs Sales by Country (2018-2024) & (K Units)
Table 32. Europe Long-acting EPO Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Long-acting EPO Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Long-acting EPO Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Long-acting EPO Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Long-acting EPO Drugs Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Long-acting EPO Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Long-acting EPO Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Long-acting EPO Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Long-acting EPO Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Long-acting EPO Drugs Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Long-acting EPO Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Long-acting EPO Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Long-acting EPO Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Long-acting EPO Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Long-acting EPO Drugs Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Long-acting EPO Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Long-acting EPO Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Long-acting EPO Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Long-acting EPO Drugs Sales (K Units) by Type (2018-2024)
Table 51. Global Long-acting EPO Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Long-acting EPO Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Long-acting EPO Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Long-acting EPO Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Long-acting EPO Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Long-acting EPO Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Long-acting EPO Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Long-acting EPO Drugs Price (US$/Unit) by Type (2018-2024)
Table 59. Global Long-acting EPO Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Long-acting EPO Drugs Sales (K Units) by Application (2018-2024)
Table 61. Global Long-acting EPO Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Long-acting EPO Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Long-acting EPO Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Long-acting EPO Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Long-acting EPO Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Long-acting EPO Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Long-acting EPO Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Long-acting EPO Drugs Price (US$/Unit) by Application (2018-2024)
Table 69. Global Long-acting EPO Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. Amgen Corporation Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Long-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Amgen Long-acting EPO Drugs Product
Table 74. Amgen Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Long-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Johnson & Johnson Long-acting EPO Drugs Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Kyowa Kirin Corporation Information
Table 81. Kyowa Kirin Description and Business Overview
Table 82. Kyowa Kirin Long-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Kyowa Kirin Long-acting EPO Drugs Product
Table 84. Kyowa Kirin Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Long-acting EPO Drugs Distributors List
Table 88. Long-acting EPO Drugs Customers List
Table 89. Long-acting EPO Drugs Market Trends
Table 90. Long-acting EPO Drugs Market Drivers
Table 91. Long-acting EPO Drugs Market Challenges
Table 92. Long-acting EPO Drugs Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Long-acting EPO Drugs
Figure 2. Global Long-acting EPO Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Long-acting EPO Drugs Market Share by Type in 2022 & 2029
Figure 4. Epoetin-alfa Product Picture
Figure 5. Epoetin-beta Product Picture
Figure 6. Darbepoetin-alfa Product Picture
Figure 7. Others Product Picture
Figure 8. Global Long-acting EPO Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Long-acting EPO Drugs Market Share by Application in 2022 & 2029
Figure 10. Anemia
Figure 11. Kidney Disorders
Figure 12. Others
Figure 13. Global Long-acting EPO Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Long-acting EPO Drugs Market Size (2018-2029) & (US$ Million)
Figure 15. Global Long-acting EPO Drugs Sales (2018-2029) & (K Units)
Figure 16. Global Long-acting EPO Drugs Average Price (US$/Unit) & (2018-2029)
Figure 17. Long-acting EPO Drugs Report Years Considered
Figure 18. Long-acting EPO Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Long-acting EPO Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Long-acting EPO Drugs Players: Market Share by Revenue in 2022
Figure 21. Long-acting EPO Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Long-acting EPO Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Long-acting EPO Drugs Sales Market Share by Country (2018-2029)
Figure 24. North America Long-acting EPO Drugs Revenue Market Share by Country (2018-2029)
Figure 25. United States Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Long-acting EPO Drugs Sales Market Share by Country (2018-2029)
Figure 28. Europe Long-acting EPO Drugs Revenue Market Share by Country (2018-2029)
Figure 29. Germany Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Long-acting EPO Drugs Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Long-acting EPO Drugs Revenue Market Share by Region (2018-2029)
Figure 36. China Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Long-acting EPO Drugs Sales Market Share by Country (2018-2029)
Figure 44. Latin America Long-acting EPO Drugs Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Long-acting EPO Drugs Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Long-acting EPO Drugs Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Long-acting EPO Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Long-acting EPO Drugs by Type (2018-2029)
Figure 54. Global Revenue Market Share of Long-acting EPO Drugs by Type (2018-2029)
Figure 55. Global Long-acting EPO Drugs Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Long-acting EPO Drugs by Application (2018-2029)
Figure 57. Global Revenue Market Share of Long-acting EPO Drugs by Application (2018-2029)
Figure 58. Global Long-acting EPO Drugs Price (US$/Unit) by Application (2018-2029)
Figure 59. Long-acting EPO Drugs Value Chain
Figure 60. Long-acting EPO Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed